tiprankstipranks
Trending News
More News >
Q32 Bio (QTTB)
NASDAQ:QTTB
US Market

Q32 Bio (QTTB) Income Statement

Compare
904 Followers

Q32 Bio Income Statement

Last quarter (Q3 2025), Q32 Bio's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Q32 Bio's net income was $-7.39M. See Q32 Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ -6.65M$ 6.65M$ 33.97M$ 2.70M
Gross Profit
$ -487.00K$ -6.65M$ 6.65M$ 24.43M$ 2.70M
Operating Expenses
$ 65.61M$ 41.60M$ 45.88M$ 120.38M$ 124.06M
Depreciation and Amortization
$ 487.00K$ 499.00K$ 370.00K$ 9.54M$ 8.90M
EBITDA
$ -45.30M$ -47.76M$ -38.85M$ -86.22M$ -119.79M
Operating Income
$ -66.10M$ -48.26M$ -39.23M$ -95.95M$ -130.26M
Other Income/Expenses
$ 18.39M$ -5.17M$ -3.52M$ 185.00K$ 1.57M
Pretax Income
$ -47.71M$ -53.42M$ -42.75M$ -95.76M$ -128.69M
Net Income
$ -47.73M$ -53.74M$ -42.81M$ -95.76M$ -128.69M
Per Share Metrics
Basic EPS
$ -5.12$ -16.70$ -13.42$ -12.23$ -50.46
Diluted EPS
$ -6.58$ -16.70$ -13.42$ -12.23$ -50.46
Weighted Average Shares Outstanding
12.20M 3.22M 3.19M 3.07M 2.55M
Weighted Average Shares Outstanding (Diluted)
12.20M 3.22M 3.19M 3.07M 2.55M
Currency in USD

Q32 Bio Earnings and Revenue History